The understanding and management of hemorrhagic shock have evolved significantly over the last 400 years. Injured patients in shock mandate immediate surgeon involvement. Every graduating surgical resident and every surgeon taking trauma call should thoroughly understand the concepts of damage control resuscitation and be prepared to care for these patients. This review seeks to revisit the history of hemorrhagic shock and the evolution of damage control resuscitation.
SheenW. The nature of surgical shock. Lancet. 1906;167:1825-1826.
15.
LattaT. Letter from Dr Latta to the secretary of the central board of health, London, affording a view of the rationale and results of his practice in the treatment of cholera by aqueous and saline injections. Int J Epidemiol. 1832;42(2):387-390.
16.
JenningsCE. The intra-venous injection of fluid for severe hemorrhage. Lancet. 1882;120:436-437.
17.
HodderEM. Transfusion of milk in cholera. The retrospect of medicine: Being a half-yearly journal. 1873;67:14-16.
18.
CowellEM. The initiation of wound shock. JAMA. 1918;70(9):607.
19.
CannonWBKeenWW. Surgery its Principles and Practice. Philadelphia, PA: W.B. Saunders; 1921.
20.
BlalockA. Principles of Surgical Care, Shock and other Problems. StLouis, MO: Mosby Company; 1940.
21.
ShiresTColnDCarricoJLightfootS. Fluid therapy in hemorrhagic shock. AMA Arch Surg. 1964;88:688-693.
22.
MoncriefJA. Burns. I. Assessment. JAMA. 1979;242(1):72-74.
23.
MattoxKL. The ebb and flow of fluid (as in resuscitation). Eur J Trauma Emerg Surg. 2015;41(2):119-127.
24.
PopeAFrenchGLongneckerDE. Fluid Resuscitation: State of the Science for Treating Combat Casualties and Civilian Injuries. Washington, DC: National Academic Press; 1999.
25.
CannonWBFraserJCowellEM. The prevention of wound shock. JAMA. 1918;70:618-621.
26.
DuttonRPMackenzieCFScaleaTM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma. 2002;52(6):1141-1146.
27.
TranAYatesJLauALampronJMatarM. Permissive hypotension versus conventional resuscitation strategies in adult trauma patients with hemorrhagic shock: A systematic review and meta-analysis of randomized controlled trials. J Trauma Acute Care Surg. 2018;84(5):802-808.
28.
DasPCSmit SibingaCTHalieMR. Supportive Therapy in Haematology. Boston, MA: Martinus Nijhoff Publishing; 1985.
29.
HallSMurphyMF. Limitations of component therapy for massive haemorrhage: Is whole blood the whole solution?Anesthesia. 2015;70(5):511-514.
30.
ComoJJDuttonRPScaleaTMEdelmanBBHessJR. Blood transfusion rates in the care of acute trauma. Transfusion. 2004;44(6):809-813.
31.
MacLeodJBLynnMMcKenneyMGCohnSMMurthaM. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55:39-44.
HessJRHolcombJBHoytDB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion. 2006;46(5):685-686.
34.
HolcombJBJenkinsDRheeP, et al.Damage control resuscitation: Directly addressing the early coagulopathy of trauma. J Trauma. 2007;62(2):307-310.
35.
BorgmanMASpinellaPCPerkinsJG, et al.The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63(4):805-813.
36.
HolcombJBTilleyBCBaraniukS, et al.Transfusion of plasma, platelets and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: The PROPPR randomized clinical trial. JAMA. 2015;313(5):471-482.
37.
CannonJWKhanMARajaAS, et al.Damage control resuscitation in patients with severe traumatic hemorrhage: A practice management guideline from the eastern association for the surgery of trauma. J Trauma Acute Care Surg. 2017;82(3):605-617.
38.
UnruhMReyesJHelmerSDHaanJM. An evaluation of blood product utilization rates with massive transfusion protocol: before and after thromboelastography (TEG) use in trauma. Am J Surg. 2019;218(6):1175-1180.
39.
AveryPMortonSTuckerHGreenLWeaverADavenportR. Whole blood transfusion versus component therapy in adult trauma patients with acute major haemorrhage. Emerg Med J. 2020;37(6):370-378.
40.
CRASH-2 Trial Collaborators, ShakurHRobertsI, et al.Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
41.
CurryNRourkeCDavenportR, et al.Early cryoprecipitate for major haemorrhage in trauma: a randomized controlled feasibility trial. Br J Anaesth. 2015;115(1):76-83.
42.
SimsCAHolenaDKimP, et al.Effects of low-dose supplementation of arginine vasopressin on need for blood product transfusion in patients with trauma and hemorrhagic shock. JAMA Surg. 2019;154(11):994-1003.
